Faculty Opinions Recommendation of the Ephrin-A1/Epha2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

doi 10.3410/f.726113961.793517448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Faculty Opinions Ltd

Related search

The Ephrin-A1 Ligand and Its Receptor, EphA2, Are Expressed During Tumor Neovascularization

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

miR-191/DAB2 Axis Regulates the Tumorigenicity of Estrogen Receptor-Positive Breast Cancer

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis

Oncoscience
Cancer ResearchOncology
2014English

New Developments in the Treatment of HER2-positive Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2012English

Glutamine Metabolism Regulates FLIP Expression and Sensitivity to TRAIL in Triple-Negative Breast Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Local Estrogen Axis in the Human Bone Microenvironment Regulates Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2017English

Faculty Opinions Recommendation of a Balance of Positive and Negative Regulators Determines the Pace of the Segmentation Clock.

2015English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy